Trial intelligence / Profile preview

COP-AF

NCT03310125Phase 3Completed

Sponsor
Population Health Research Institute
Start
Feb 2018
Primary completion
Jun 2023
Modality
Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
Countries
11
01

Overview

A Phase 3 trial of colchicine in Atrial fibrillation (AFib), myocardial injury after non-cardiac surgery (MINS), sponsored by Population Health Research Institute. Started Feb 2018; status: completed.

02

Drugs

colchicine
03

Conditions

Atrial fibrillation (AFib)myocardial injury after non-cardiac surgery (MINS)

Beyond the preview

Go deeper on NCT03310125.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03310125.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call